Guidance particularly addresses the value of ultrasound in patient-provider shared decision-making in management of care.

Low patient satisfaction in psoriasis and psoriatic arthritis for clinicians and treatment is tied to need for better ...

Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the "Company”), a clinical-stage macrophage reprogramming immunotherapy company, ...

The following is a summary of “Association between depression and anxiety and inability to achieve remission in rheumatoid ...

Enlivex (ENLV) has released an update. Enlivex Therapeutics has announced the successful dosing of the first patient in a Phase I trial to test ...

in patients with active psoriatic arthritis (PsA). PsA is a chronic, debilitating and progressive inflammatory condition that ...

Global Healthy Living Foundation has 12 posters and Polymyalygia Rheumataca, Psoriasis and RA Research at American College of ...

MoonLake Immunotherapeutics (MLTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday.

Discover how global recruitment trends influence placebo response rates in Psoriatic Arthritis trials, revealing critical ...

Similar percentages of patients with PsA receiving secukinumab vs adalimumab achieved an ACR20 response at 12 weeks.

Researchers at the University of Massachusetts Amherst have invented a new, sprayable delivery system for psoriasis ...

As we previously reported, this August the European Commission granted approval for Celltrion’s STELARA biosimilar, STEQEYMA. Earlier this ...